Pharmacological approaches to the treatment of ischaemic neuronal damage

Eye (Basingstoke)

Volumn 5, Issue 2, 1991, Pages 193-197

  Iversen, L L ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Dizocilpine; Glutamate; Ischaemic; MK 801; Neuroprotective agents; NMDA receptor

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DEXTROMETHORPHAN; DIZOCILPINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE AGONIST; PHENCYCLIDINE; QUINOXALINE DERIVATIVE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOXIA; CONFERENCE PAPER; HYPOGLYCEMIA; ISCHEMIA; NERVE CELL LESION; NONHUMAN; RETINA;

ANIMAL; ISCHEMIA; MICE; NEUROTOXINS; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL DISEASES; RETINAL VESSELS;

EID: 0026095131     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.1991.34     Document Type: Article

References (21)

1. Krieglstein J (ed): ‘Pharmacology of Cerebral Ischaemia 1988, CRC Press, Boca Raton, Florida, 1989.
2. Krieglstein J (ed): ‘Pharmacology of Cerebral Ischaemia 1990’, CRC Press, Boca Raton, Florida (in press).
3. Fieschi C and Lenzi GL (eds.): Proceedings of Brain 89.J Cerebral Blood Flow Metab 1989, 9: Suppl 1.
4. Lucas DR and Newhouse JP: The toxic effects of L-glutamate on the inner layers of the retina. Arch Ophthalmol 1957, 58: 193-201.
5. Olney JW: Brain lesions obesity and other disturbances in mice treated with monosodium glutamate. Science 1969, 164: 719-21.
6. Olney JW: The toxic effects of glutamate and related compounds in the retina and the brain. Retina 1982, 2: 341-59.
7. Watkins JC and Evans RH: Excitatory amino acid transmitters. Ann Rev Pharmacal Toxicol 1981, 21: 165-204.
8. Schwarcz R and Meldrum B: Excitatory amino acid antagonists provide a therapeutic approach to neurological disorders. Lancet 1985, ii, 140-3.
9. Rothman S: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death.J Neuroscience 1984, 4: 1884-91.
10. Cotman CW and Iversen LL: Excitatory amino acids in the brain—focus on NMDA receptors. Trends in Neurosciences 1987, 10: 263-301.
11. Foster AC and Fagg GE: Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors. Brain Res Rev 1984, 7: 103-64.
12. Watkins JC and Collingridge GL (eds): The NMDA Receptor’, IRL Press, Oxford, 1989.
13. Honore T, Davies SD, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE: Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science 1988, 241: 701-3.
14. Olney J, Price M, Salles S, Labruyere J, Frierdich G: MK-801 powerfully protects against N-methyl aspartate neurotoxicity. Euro J Pharmacol 1987, 141: 357-61.
15. Choi DW, Koh JY, Peters S: Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosc 1988, 8: 185-96.
16. Zeevalk GD and Nicklas WJ: Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina. Pharmacol Exp Therapeut 1990, 253: 1283-92.
17. Price MT, Honore T, Mueller MEM, Labruyere J, Silverman E, Olney J, CNQX potently and selectively blocks kainate excitotoxicity in the chick embryo retina. Society for Neuroscience (Abstracts) 1988, 14: 418.
18. David P, Lusky M, Teichberg VI. Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp Eye Res 1988, 46: 657-62.
19. Levy DI and Lipton SA: Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology 1990, 40: 852-55.
20. Meldrum BS, Chapman AG, Patel S, Swan J: Competitive NMDA antagonists as drugs. In ‘The NMDA Receptor’ eds. J.C. Watkins & G. L. Collingridge, pp 207-216, IRL Press, Oxford, 1989.
21. Iversen LL, Woodruff GN, Kemp JA, Foster AC, McKernan R, Gill R, Wonge HF: Non-competitive NMDA antagonists as drugs. Competitive NMDA antagonists as drugs, pp 217-226.